Showing results (101-110 of 127) with videos related to

Sort By:
Pageof 13
Clinical Lymphoma, Myeloma & Leukemia|May 31, 2022
Isatuximab-Pomalidomide-Dexamethasone Versus Pomalidomide-Dexamethasone in East Asian Patients With Relapsed/Refractory Multiple Myeloma: ICARIA-MM Subgroup AnalysisKazutaka Sunami, Takashi Ikeda, Shang-Yi Huang, et al.
Ejhaem|July 18, 2022
Significance of maintenance therapy after HDT/ASCT in symptomatic multiple myeloma: A multicenter retrospective analysis in Kansai Myeloma ForumAya Nakaya, Hirohiko Shibayama, Eiji Nakatani, et al.
Internal Medicine (Tokyo, Japan)|May 8, 2013
The response to second-line induction with bortezomib and dexamethasone is predictive of long-term outcomes prior to high-dose chemotherapy with autologous stem cell transplantation for multiple myelomaTsutomu Kobayashi, Junya Kuroda, Shin-ichi Fuchida, et al.
Blood|July 29, 2004
Feasibility of HLA-haploidentical hematopoietic stem cell transplantation between noninherited maternal antigen (NIMA)-mismatched family members linked with long-term fetomaternal microchimerismTatsuo Ichinohe, Takashi Uchiyama, Chihiro Shimazaki, et al.
International Journal of Hematology|November 12, 2014
Impact of early use of lenalidomide and low-dose dexamethasone on clinical outcomes in patients with relapsed/refractory multiple myelomaTsutomu Kobayashi, Junya Kuroda, Shin-ichi Fuchida, et al.
Cancer Reports (Hoboken, N.J.)|June 14, 2021
Prognostic impact of resistance to bortezomib and/or lenalidomide in carfilzomib-based therapies for relapsed/refractory multiple myeloma: The Kyoto Clinical Hematology Study Group, multicenter, pilot, prospective, observational study in Asian patientsYuka Kawaji-Kanayama, Tsutomu Kobayashi, Ayako Muramatsu, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|July 27, 2007
Intracoronary transplantation of non-expanded peripheral blood-derived mononuclear cells promotes improvement of cardiac function in patients with acute myocardial infarctionTetsuya Tatsumi, Eishi Ashihara, Toshihide Yasui, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|August 9, 2016
Second primary malignancies among patients with myeloma-related-diseases in the KMF databaseSatoru Kosugi, Hirohiko Shibayama, Eiji Nakatani, et al.
International Journal of Hematology|January 24, 2022
Clinical impacts of frailty, poor performance status, and advanced age in carfilzomib-containing treatment for relapsed/refractory multiple myeloma: post hoc investigation of the KOTOSG multicenter pilot prospective observational studyYuka Kawaji-Kanayama, Ayako Muramatsu, Nana Sasaki, et al.
Annals of Hematology|March 2, 2023
Daratumumab plus bortezomib, cyclophosphamide, and dexamethasone in Asian patients with newly diagnosed AL amyloidosis: subgroup analysis of ANDROMEDAKenshi Suzuki, Ashutosh D Wechalekar, Kihyun Kim, et al.
Pageof 13